CTS Corporation - CTS

CTS Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CTS	0.5	2.3	-7.2	4.6	-3.8	28.0	46.4	64.7	226.6	1299.5
S&P 500	1.0	1.8	-0.9	2.7	7.3	26.5	31.0	80.1	196.5	33856.2

Compare CTS with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CTS
name	CTS Corporation
price	51.64
changes percentage	0.4865
change	0.25
day low	51.24
day high	52.17
year high	59.68
year low	40.92
market cap	1555164420
price avg 50	54.0732
price avg 200	50.19695
exchange	NYSE
volume	77436
avg volume	146719
open	52.17
previous close	51.39
eps	1.94
pe	26.62
earnings announcement	2025-02-04T13:30:00.000+0000
shares outstanding	30115500
timestamp	2025-01-17 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 52.7%

Overall Quarterly Financial Health: 53.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000026058
revenue	550422000	586869000	-6.21
gross profit	190859000	210538000	-9.35
gross profit ratio	0.35	0.36	-3.34
research and development expenses	24918000	24100000	3.39
operating expenses	115808000	115620000	0.16
interest income	4625000	1326000	248.79
interest expense	3331000	2192000	51.96
ebitda	107194000	113220000	-5.32
ebitdaratio	0.19	0.14	34.71
operating income	75051000	55088000	36.24
operating income ratio	0.14	0.09	45.26
net income	60532000	59575000	1.61
net income ratio	0.11	0.1	8.33
eps	1.93	1.86	3.76

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 550 million in 2023 from 587 million in 2022 representing a change of -6.21%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 191 million in 2023 from 211 million in 2022 representing a change of -9.35%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 116 million in 2023 from 116 million in 2022 representing a change of 0.16%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 107 million in 2023 from 113 million in 2022 representing a change of -5.32%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 25 million in 2023 from 24 million in 2022 representing a change of 3.39%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 75 million in 2023 from 55 million in 2022 representing a change of 36.24%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 61 million in 2023 from 60 million in 2022 representing a change of 1.61%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.93 in 2023 from 1.93 in 2022 representing a change of 3.76%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000026058
revenue	132424000	130092000	1.79
gross profit	49788000	46686000	6.64
gross profit ratio	0.38	0.36	4.77
research and development expenses	5031000	6086000	-17.33
operating expenses	27540000	27418000	0.44
interest income	973000	1441000	-32.48
interest expense	1307000	833000	56.90
ebitda	32197000	26393000	21.99
ebitdaratio	0.24	0.2	18.94
operating income	21475000	19268000	11.45
operating income ratio	0.16	0.15	9.49
net income	18683000	14707000	27.03
net income ratio	0.14	0.11	24.80
eps	0.62	0.48	29.17

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 132 million in 2024Q3 from 130 million in 2024Q2 representing a change of 1.79%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 50 million in 2024Q3 from 47 million in 2024Q2 representing a change of 6.64%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 32 million in 2024Q3 from 26 million in 2024Q2 representing a change of 21.99%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 21 million in 2024Q3 from 19 million in 2024Q2 representing a change of 11.45%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 19 million in 2024Q3 from 15 million in 2024Q2 representing a change of 27.03%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.62 in 2024Q3 from 0.62 in 2024Q2 representing a change of 29.17%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 5 million in 2024Q3 from 6 million in 2024Q2 representing a change of -17.33%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 28 million in 2024Q3 from 27 million in 2024Q2 representing a change of 0.44%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000026058
total assets	741167000	748487000	-0.98
total liabilities	214345000	242263000	-11.52
total equity	526822000	506224000	4.07
cash and cash equivalents	163876000	156910000	4.44
short term investments	0	1561000	-100.00
long term investments	706000	1434000	-50.77
total current assets	319349000	325760000	-1.97
total non current assets	421818000	422727000	-0.22
total current liabilities	97039000	112532000	-13.77
total non current liabilities	117306000	129731000	-9.58
common stock	319269000	316803000	0.78
retained earnings	602232000	546703000	10.16
total debt	96859000	109360000	-11.43

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 741 million in 2023 from 748 million in 2022 representing a change of -0.98%. Suggesting a decrease in asset holdings.

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 2 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 319 million in 2023 from 326 million in 2022 representing a change of -1.97%. This indicates a worsen liquidity position.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 214 million in 2023 from 242 million in 2022 representing a change of -11.52%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 527 million in 2023 from 506 million in 2022 representing a change of 4.07%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 164 million in 2023 from 157 million in 2022 representing a change of 4.44%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 97 million in 2023 from 113 million in 2022 representing a change of -13.77%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 319 in 2023 from 317 in 2022 representing a change of 0.78%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 602 million in 2023 from 547 million in 2022 representing a change of 10.16%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 97 million in 2023 from 109 million in 2022 representing a change of -11.43%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000026058
total assets	789392000	725622000	8.79
total liabilities	258586000	202871000	27.46
total equity	530806000	522751000	1.54
cash and cash equivalents	94875000	161246000	-41.16
short term investments	0	1183000	-100.00
long term investments	334000	1061000	-68.52
total current assets	255561000	314862000	-18.83
total non current assets	533831000	410759999	29.96
total current liabilities	103799000	92447000	12.28
total non current liabilities	154787000	110424000	40.18
common stock	321924000	321894000	0.01
retained earnings	643088000	625614000	2.79
total debt	129307000	92112000	40.38

Overall Score of Quarterly Balance Sheet

0.4 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 789 million in 2024Q3 from 726 million in 2024Q2 representing a change of 8.79%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 531 million in 2024Q3 from 523 million in 2024Q2 representing a change of 1.54%. This indicates an increase in shareholders' equity.

  Common Stock: Common Stock increased to 322 in 2024Q3 from 322 in 2024Q2 representing a change of 0.01%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 643 million in 2024Q3 from 626 million in 2024Q2 representing a change of 2.79%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 259 million in 2024Q3 from 203 million in 2024Q2 representing a change of 27.46%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 95 million in 2024Q3 from 161 million in 2024Q2 representing a change of -41.16%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 0 million in 2024Q3 from 1 million in 2024Q2 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 256 million in 2024Q3 from 315 million in 2024Q2 representing a change of -18.83%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 104 million in 2024Q3 from 92 million in 2024Q2 representing a change of 12.28%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 129 million in 2024Q3 from 92 million in 2024Q2 representing a change of 40.38%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000026058
net change in cash	6966000	15445000	-54.90
operating cash flow	88811000	121197000	-26.72
free cash flow	74073000	106864000	-30.68
capital expenditure	-14738000	-14333000	-2.83
depreciation and amortization	28710000	29753000	-3.51
deferred income tax	-4046000	492000	-922.36
stock based compensation	5181000	7726000	-32.94
accounts payables	-9751000	-2293000	-325.25
inventory	2353000	-8211000	128.66
acquisitions net	-3359000	-96855000	96.53
investments in property plant and equipment	-14738000	-14333000	-2.83
net cash used for investing activites	-18097000	-111188000	83.72
debt repayment	-16170000	33638000	-148.07
common stock issued	0	0	NaN
common stock repurchased	-40926000	-21447000	-90.82
dividends paid	-5040000	-5131000	1.77
net cash used provided by financing activities	-65399000	4336000	-1608.28
cash at end of period	163876000	156910000	4.44
accounts receivables	12590000	-5913000	312.92
cash at beginning of period	156910000	141465000	10.92

Overall Score of Annual Cashflow Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 7 million in 2023 from 15 million in 2022 representing a change of -54.9%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 89 million in 2023 from 121 million in 2022 representing a change of -26.72%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 74 million in 2023 from 107 million in 2022 representing a change of -30.68%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables increased to 10 million in 2023 from 2 million in 2022 representing a change of -325.25%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 13 in 2023 from -6 million in 2022 representing a change of 312.92%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -15 million in 2023 from -14 million in 2022 representing a change of -2.83%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 5 million in 2023 from 8 million in 2022 representing a change of -32.94%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Dividends Paid: Dividends Paid increased to -5 million in 2023 from -5 million in 2022 representing a change of 1.77%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000026058
operating cash flow	35395000	19629000	80.32
free cash flow	31524000	14992000	110.27
capital expenditure	-3871000	-4637000	16.52
depreciation and amortization	7993000	7325000	9.12
deferred income tax	-547000	-615000	11.06
stock based compensation	1448000	1323000	9.45
accounts receivables	912000	-4899000	118.62
accounts payables	1902000	-4883000	138.95
inventory	3681000	6009000	-38.74
acquisitions net	-121912000	0	NaN
investments in property plant and equipment	-3871000	-4637000	16.52
net cash used for investing activites	-125783000	-4637000	-2612.59
debt repayment	37700000	-2500000	1608.00
common stock issued	0	0	NaN
common stock repurchased	-11895000	-10934000	-8.79
dividends paid	-1217000	-1227000	0.81
net cash used provided by financing activities	24565000	-15751000	255.96
net change in cash	-66371000	-1179000	-5529.43
cash at end of period	94875000	161246000	-41.16
cash at beginning of period	161246000	162425000	-0.73

Overall Score of Quarterly Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -66 million in 2024Q3 from -1 million in 2024Q2 representing a change of -5529.43%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -4 million in 2024Q3 from -5 million in 2024Q2 representing a change of 16.52%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to -1 million in 2024Q3 from -1 million in 2024Q2 representing a change of 11.06%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 1 million in 2024Q3 from 1 million in 2024Q2 representing a change of 9.45%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 1 in 2024Q3 from -5 million in 2024Q2 representing a change of 118.62%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 35 million in 2024Q3 from 20 million in 2024Q2 representing a change of 80.32%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 32 million in 2024Q3 from 15 million in 2024Q2 representing a change of 110.27%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 2 million in 2024Q3 from 5 million in 2024Q2 representing a change of 138.95%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid increased to -1 million in 2024Q3 from -1 million in 2024Q2 representing a change of 0.81%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	17.55	18.36	-4.39
net income per share	1.93	1.86	3.58
operating cash flow per share	2.83	3.79	-25.30
free cash flow per share	2.36	3.34	-29.34
cash per share	5.23	4.96	5.42
book value per share	16.8	15.84	6.09
tangible book value per share	8.46	7.69	9.99
shareholders equity per share	16.8	15.84	6.09
interest debt per share	3.19	3.49	-8.44
market cap	1371642660	1260178560	8.85
enterprise value	1304625660	1212628560	7.59
pe ratio	22.66	21.15	7.12
price to sales ratio	2.49	2.15	16.05
pocfratio	15.44	10.4	48.54
pfcf ratio	18.52	11.79	57.03
pb ratio	2.6	2.49	4.59
ptb ratio	2.6	2.49	4.59
ev to sales	2.37	2.07	14.71
enterprise value over ebitda	12.17	10.71	13.63
ev to operating cash flow	14.69	10.01	46.82
ev to free cash flow	17.61	11.35	55.21
earnings yield	0.04	0.05	-6.65
free cash flow yield	0.05	0.08	-36.32
debt to equity	0.18	0.22	-14.89
debt to assets	0.13	0.15	-10.56
net debt to ebitda	-0.63	-0.42	-48.86
current ratio	3.29	2.89	13.68
interest coverage	22.53	25.13	-10.35
income quality	1.47	2.03	-27.88
dividend yield	0.0	0.0	-9.76
payout ratio	0.08	0.09	-3.33
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.05	0.04	10.24
intangibles to total assets	0.35	0.35	1.45
capex to operating cash flow	0.17	0.12	40.32
capex to revenue	0.03	0.02	9.63
capex to depreciation	0.51	0.48	6.56
stock based compensation to revenue	0.01	0.01	-28.50
graham number	27.01	25.77	4.83
roic	0.09	0.06	47.64
return on tangible assets	0.13	0.12	3.41
graham net net	1.23	0.49	152.40
working capital	222310000	213228000	4.26
tangible asset value	265227000	245810000	7.90
net current asset value	105004000	83497000	25.76
invested capital	602922000	593644000	1.56
average receivables	84752000	86563000	-2.09
average payables	48355000	54374000	-11.07
average inventory	61145500	55883000	9.42
days sales outstanding	52.1	56.56	-7.88
days payables outstanding	44.16	51.61	-14.44
days of inventory on hand	60.94	60.39	0.92
receivables turnover	7.01	6.45	8.55
payables turnover	8.27	7.07	16.88
inventory turnover	5.99	6.04	-0.91
roe	0.11	0.12	-2.37
capex per share	0.47	0.45	4.82

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 22.66 on 2023-12-31 from 21.15 on 2022-12-31, representing a change of 7.12%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.18 on 2023-12-31 from 0.22 on 2022-12-31, representing a change of -14.89%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio increased to 3.29 on 2023-12-31 from 2.89 on 2022-12-31, representing a change of 13.68%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
CTS
calendar year	2024	2024	NaN
revenue per share	4.37	4.26	2.50
net income per share	0.62	0.48	27.92
operating cash flow per share	1.17	0.64	81.58
free cash flow per share	1.04	0.49	111.74
cash per share	3.13	5.32	-41.18
book value per share	17.52	17.13	2.25
tangible book value per share	5.12	8.84	-42.12
shareholders equity per share	17.52	17.13	2.25
interest debt per share	4.31	3.05	41.51
market cap	1465914000	1496564550	-2.05
enterprise value	1500346000	1427430550	5.11
pe ratio	19.62	25.44	-22.89
price to sales ratio	11.07	11.5	-3.77
pocfratio	41.42	76.24	-45.68
pfcf ratio	46.5	99.82	-53.42
pb ratio	2.76	2.86	-3.53
ptb ratio	2.76	2.86	-3.53
ev to sales	11.33	10.97	3.26
enterprise value over ebitda	46.6	54.08	-13.84
ev to operating cash flow	42.39	72.72	-41.71
ev to free cash flow	47.59	95.21	-50.01
earnings yield	0.01	0.01	29.69
free cash flow yield	0.02	0.01	114.67
debt to equity	0.24	0.18	38.25
debt to assets	0.16	0.13	29.04
net debt to ebitda	1.07	-2.62	140.83
current ratio	2.46	3.41	-27.71
interest coverage	16.43	23.13	-28.97
income quality	1.89	1.33	41.95
dividend yield	0.0	0.0	1.26
payout ratio	0.07	0.08	-21.92
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.04	0.05	-18.79
intangibles to total assets	0.48	0.35	36.56
capex to operating cash flow	0.11	0.24	-53.70
capex to revenue	0.03	0.04	-17.99
capex to depreciation	0.48	0.63	-23.50
stock based compensation to revenue	0.01	0.01	7.52
graham number	15.59	13.63	14.37
roic	0.03	0.02	3.55
return on tangible assets	0.05	0.03	45.16
graham net net	-2.32	1.62	-243.22
working capital	151762000	222415000	-31.77
tangible asset value	155113000	269863000	-42.52
net current asset value	-3025000	111991000	-102.70
invested capital	644609000	591243000	9.03
average receivables	85867500	83021500	3.43
average payables	42907500	43236500	-0.76
average inventory	54479000	54727000	-0.45
days sales outstanding	58.69	59.07	-0.64
days payables outstanding	48.96	44.09	11.03
days of inventory on hand	62.39	55.75	11.91
receivables turnover	1.53	1.52	0.64
payables turnover	1.84	2.04	-9.93
inventory turnover	1.44	1.61	-10.64
roe	0.04	0.03	25.11
capex per share	0.13	0.15	-15.94

• Negative

  ROE: Return on Equity (ROE) increased to 0.04 on 2024-09-30 Q3 from 0.03 on 2024-06-30 Q2, representing a change of 25.11%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 19.62 on 2024-09-30 Q3 from 25.44 on 2024-06-30 Q2, representing a change of -22.89%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 2.46 on 2024-09-30 Q3 from 3.41 on 2024-06-30 Q2, representing a change of -27.71%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.24 on 2024-09-30 Q3 from 0.18 on 2024-06-30 Q2, representing a change of 38.25%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 71.2 which is higher than current price 51.64, indicates the company may be undervalued.